Literature DB >> 9383599

New developments in ultrasound systems for contrast echocardiography.

S Kaul1.   

Abstract

Contrast echocardiography (CE) has evolved significantly in the past decade. Contrast agents and the hardware and software used to detect them and display optimal images have developed in tandem. Not only are hardware and contrast agents available that allow left ventricular cavity enhancement, but recent research points to the usefulness of CE for the evaluation of myocardial perfusion in the cardiac catheterization laboratory and operating room. Advances in ultrasound technology, such as transient harmonic imaging and integrated backscatter, coupled with the development of newer contrast agents that contain smaller, more stable microbubbles capable of transpulmonary passage for intravenous injection, promise a vast increase in the applications of CE in clinical practice.

Mesh:

Substances:

Year:  1997        PMID: 9383599      PMCID: PMC6656200          DOI: 10.1002/clc.4960201307

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging.

Authors:  J Hancock; H Dittrich; D E Jewitt; M J Monaghan
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

2.  Prevalence and development of additional cardiac abnormalities in 1448 patients with congenital ventricular septal defects.

Authors:  S Glen; J Burns; P Bloomfield
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.